NCT03150732View on ClinicalTrials.gov

Systemic Nalbuphine Versus Intravenous Regional Anesthesia

NACompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

August 10, 2022

Primary Completion Date

February 10, 2024

Study Completion Date

February 10, 2024

Conditions
Postoperative Pain
Interventions
DRUG

Systemic nalbuphine

Patients will receive systemic nalbuphine 10 mg

DRUG

Local nalbuphine

Patients will receive local nalbuphine 10 mg

Trial Locations (1)

71526

Mohamed H Bakri, Asyut

All Listed Sponsors
lead

Assiut University

OTHER